NDC 17772-101

Trokendi XR

Topiramate

Trokendi XR is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Supernus Pharmaceuticals. The primary component is Topiramate.

Product ID17772-101_849fe8c8-6088-77c3-e053-2a91aa0ad729
NDC17772-101
Product TypeHuman Prescription Drug
Proprietary NameTrokendi XR
Generic NameTopiramate
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2013-08-16
Marketing CategoryNDA / NDA
Application NumberNDA201635
Labeler NameSupernus Pharmaceuticals
Substance NameTOPIRAMATE
Active Ingredient Strength25 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 17772-101-01

100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-101-01)
Marketing Start Date2013-08-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 17772-101-15 [17772010115]

Trokendi XR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201635
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-08-16
Marketing End Date2017-10-30

NDC 17772-101-30 [17772010130]

Trokendi XR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201635
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-08-16

NDC 17772-101-03 [17772010103]

Trokendi XR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-16
Marketing End Date2019-03-21

NDC 17772-101-12 [17772010112]

Trokendi XR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-16

NDC 17772-101-10 [17772010110]

Trokendi XR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201635
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-08-16

NDC 17772-101-01 [17772010101]

Trokendi XR CAPSULE, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA201635
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-08-16

Drug Details

Active Ingredients

IngredientStrength
TOPIRAMATE25 mg/1

OpenFDA Data

SPL SET ID:2dc7957e-a3e5-46bb-aa66-f3250f872f5e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1436239
  • 1437288
  • 1436245
  • 1437283
  • 1437280
  • 1437278
  • 1437290
  • 1437285
  • Pharmacological Class

    • Decreased Central Nervous System Disorganized Electrical Activity [PE]
    • Cytochrome P450 3A4 Inducers [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]

    Medicade Reported Pricing

    17772010130 TROKENDI XR 25 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    17772010115 TROKENDI XR 25 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    17772010101 TROKENDI XR 25 MG CAPSULE

    Pricing Unit: EA | Drug Type:

    NDC Crossover Matching brand name "Trokendi XR" or generic name "Topiramate"

    NDCBrand NameGeneric Name
    17772-104Trokendi XRTrokendi XR
    17772-103Trokendi XRTrokendi XR
    17772-102Trokendi XRTrokendi XR
    17772-101Trokendi XRTrokendi XR
    0245-1071QUDEXYTopiramate
    0245-1072QUDEXYTopiramate
    0245-1073QUDEXYTopiramate
    0245-1074QUDEXYTopiramate
    0245-1075QUDEXYTopiramate
    0093-7335TopiramateTopiramate
    0093-7336TopiramateTopiramate
    0615-7562TopiramateTopiramate
    0615-7563TopiramateTopiramate
    0615-7564TopiramateTopiramate
    0615-7565TopiramateTopiramate
    0615-8138TopiramateTopiramate
    0615-8139TopiramateTopiramate

    Trademark Results [Trokendi XR]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TROKENDI XR
    TROKENDI XR
    85644722 4498773 Live/Registered
    Supernus Pharmaceuticals, Inc.
    2012-06-06

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.